(EMSRI) Amundi Index MSCI Emerging - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU1861138961 • Global Emerging Markets Equity
EMSRI: Stocks, Bonds, Emerging Markets, Sustainability, Investments
Amundi Index MSCI Emerging Markets SRI UCITS ETF (EMSRI), listed on Euronext Paris, is a French-originated ETF focusing on global emerging markets equity with an AUM of 1428.34M EUR. As a passively managed fund, it doesnt rely on traditional valuation metrics like P/E or P/B, emphasizing index replication over stock selection.
EMSRI employs a passive investment strategy, tracking the Morningstar EM Total Return Net USD Index. This approach incorporates ESG criteria, aligning with sustainable investing principles. The funds UCITS compliance ensures it meets European regulatory standards, making it accessible to a broad investor base.
The Morningstar index offers extensive coverage of emerging markets, providing diversified exposure across key regions and sectors. Its designed for investors seeking broad market representation beyond traditional indices, with a focus on risk-adjusted returns.
Key considerations for investors include understanding the funds index methodology, the inherent risks of emerging markets, potential tracking difference, and the funds appeal to ESG-focused investors. These factors highlight EMSRIs role in portfolios seeking diversified, ESG-conscious exposure to emerging markets.
Additional Sources for EMSRI ETF
EMSRI ETF Overview
Market Cap in USD | 1,555m |
Category | Global Emerging Markets Equity |
TER | 0.25% |
IPO / Inception | 2019-01-16 |
EMSRI ETF Ratings
Growth 5y | 32.7% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -1.08 |
Analysts | - |
Fair Price Momentum | 46.28 EUR |
Fair Price DCF | - |
EMSRI Dividends
No Dividends PaidEMSRI Growth Ratios
Growth Correlation 3m | -6.4% |
Growth Correlation 12m | 81.1% |
Growth Correlation 5y | -3.3% |
CAGR 5y | 8.15% |
CAGR/Max DD 5y | 0.32 |
Sharpe Ratio 12m | 0.75 |
Alpha | -0.59 |
Beta | 0.63 |
Volatility | 21.00% |
Current Volume | 5k |
Average Volume 20d | 4.2k |
As of March 14, 2025, the stock is trading at EUR 50.90 with a total of 4,995 shares traded.
Over the past week, the price has changed by -2.02%, over one month by -6.82%, over three months by -6.65% and over the past year by +5.29%.
Neither. Based on ValueRay Analyses, Amundi Index MSCI Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 32.70 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMSRI as of March 2025 is 46.28. This means that EMSRI is currently overvalued and has a potential downside of -9.08%.
Amundi Index MSCI Emerging has no consensus analysts rating.
According to ValueRays Forecast Model, EMSRI Amundi Index MSCI Emerging will be worth about 51.3 in March 2026. The stock is currently trading at 50.90. This means that the stock has a potential upside of +0.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 51.3 | 0.7% |